Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
179.87
+5.08 (2.91%)
At close: Jun 3, 2026, 4:00 PM EDT
179.87
0.00 (0.00%)
After-hours: Jun 3, 2026, 5:15 PM EDT
CRL Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, CRL stock has a consensus rating of "Buy" and an average price target of $212.27. The average 1-year stock price forecast is 18.01% higher than the current stock price, while the lowest is $135 (-24.95%) and the highest is $265 (+47.33%).
Price Target: $212.27 (+18.01%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 10 | 10 |
| Buy | 1 | 1 | 1 | 1 | 2 | 3 |
| Hold | 7 | 7 | 7 | 6 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Michael Luo CFA CLSA | CLSA | Buy Upgrades $167 → $219 | Buy | Upgrades | $167 → $219 | +21.75% | May 29, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $185 → $168 | Hold | Maintains | $185 → $168 | -6.34% | May 12, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $235 | Buy | Maintains | $235 | +30.65% | May 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $200 → $220 | Buy | Maintains | $200 → $220 | +22.31% | May 8, 2026 |
Financial Forecast
Revenue This Year
3.88B
from 4.02B
Decreased by -3.30%
Revenue Next Year
3.97B
from 3.88B
Increased by 2.16%
EPS This Year
11.22
from -2.91
EPS Next Year
12.44
from 11.22
Increased by 10.90%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.1B | 4.2B | ||||||
| Avg | 3.9B | 4.0B | ||||||
| Low | 3.7B | 3.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.3% | 9.3% | ||||||
| Avg | -3.3% | 2.2% | ||||||
| Low | -7.0% | -3.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.89 | 14.67 | ||||||
| Avg | 11.22 | 12.44 | ||||||
| Low | 10.79 | 11.42 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 30.7% | ||||||
| Avg | - | 10.9% | ||||||
| Low | - | 1.8% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.